ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,450.00
+140.00 (6.06%)
At close: Jun 26, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 61.72 billion as of June 29, 2026. Its market cap has increased by 204.54% in one year.
Market Cap
61.72B
Enterprise Value
68.48B
Revenue
12.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,450.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 61.72B, an increase of 143.50%. That is a compound annual growth rate of 14.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 61.72B | 85.83% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 77.94B |
| SunBio,Inc. | 73.89B |
| AriBioLab | 69.85B |
| Ark Solutions | 68.91B |
| BIO-FD&C | 68.17B |
| CTCBIO | 66.23B |
| QuadMedicine | 63.27B |
| Naturalendo Tech | 59.45B |